Prospective audit of cytomegalovirus-negative blood product utilization in haematology/oncology patients

Transfusion Medicine

Volumn 9, Issue 3, 1999, Pages 195-198

  Chang, H ^a   Hawes, J ^a   Hall, G A ^a   Fuller, K ^a   Francombe, W H ^a   Zuber, E ^a   Sher, G D ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

CMV negative blood products; Transfusion utilization

Indexed keywords

VIRUS ANTIBODY;

ARTICLE; BLOOD; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; CYTOMEGALOVIRUS; ECONOMICS; ERYTHROCYTE TRANSFUSION; HEMATOLOGIC DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MEDICAL AUDIT; NEOPLASM; PROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION; UTILIZATION REVIEW; VIROLOGY;

ANTIBODIES, VIRAL; BLOOD; BLOOD TRANSFUSION; COST-BENEFIT ANALYSIS; CYTOMEGALOVIRUS; ERYTHROCYTE TRANSFUSION; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; MEDICAL AUDIT; NEOPLASMS; PLATELET TRANSFUSION; PROSPECTIVE STUDIES;

EID: 0033200258     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.1999.00198.x     Document Type: Article

References (17)

1. AuBuchon, J. (1996) Cost-effectiveness of preoperative autologous blood donation for orthopedic and cardiac surgeries. American Journal of Medicine, 101 (Suppl. 2A), 38S-42S.
2. Barnett, G.O., Winickoff, R., Dorsey, J.L., Morgan, M.M. & Iurie, R.S. (1978) Quality assurance through automated monitoring and concurrent feedback using a computer based medical information system. Medical Care, 6, 962-970.
3. Expert Working Group. (1997) Guidelines for red blood cell and plasma transfusion for adults and children. Canadian Medicine Association Journal, 156 (Suppl. 11) S1-S23.
4. Goodnough, L.T., Bodner, M.S. & Martin, J.M. (1994) Blood transfusion and blood conservation: Cost and utilisation issues. American Journal of Medical Quality, 9, 172-183.
5. Hasley, P.B., Lave, T.R. & Kapoor, W.N. (1994) The necessary and unnecessary transfusion: a critical review of reported appropriateness rates and criteria for red cell transfusions. Transfusion, 34, 110-115.
6. Heaton, W.A.L. (1994) Changing patterns of blood use. Transfusion, 34, 365-367.
7. Lam, H.T.C., Schweitzer, S.O., Petz, L. et al. (1996) Are retrospective peer-review transfusion monitoring systems effective in reducing red blood cell utilisation? Archives of Pathology and Laboratory Medicine, 120, 810-816.
8. Marconi, M., Almini, D., Pizzi, N., et al. (1996) Quality assurance of clinical transfusion practice by implementation of the privilege of blood prescriptions and computerized prospective audit of blood requests. Transfusion Medicine, 6, 11-19.
9. Mozes, B., Epstein, M., Ben-bassat, I., Modan, B. & Halkin, H. (1989) Evaluation of appropriateness of blood and blood product transfusion using present criteria. Transfusion, 29, 473-476.
10. Pritchard, S.L. & Rogers, P.C. (1987) Rationale and recommendations for irradiation of blood products. Critical Reviews in Oncology and Haematology, 7, 115-124.
11. Przepiorka, D., Le Parc, G.F. & Werch, J. (1996) Prevention of transfusion-associated cytomeglovirus infection. American Journal of Clinical Pathology, 106, 163-169.
12. Restuccia, J.D. (1981) The effect of concurrent feedback in reducing inappropriate hospital utilisation. Medical Care, 20, 46-62.
13. Salem-Schatz, S.R., Avorn, J. & Soumerai, S.B. (1990) Influence of clinical knowledge, organization context, and practice style on transfusion decision making: implication for practice change strategies. Journal of the American Medical Association, 264, 471-475.
14. Sanazuro, P.J. & Worth, R.M. (1978) Concurrent quality assurance in hospital care: report of a study by private initiative in PSRO. New England Journal of Medicine, 218, 1711-1717.
15. Stehling, L., Luban, N.L.C., Anderson, K.C., Sayers, M.H., Long, A., Attar, S., Leitman, S.F., Gould, S., Kruskall, M.S., Goodnough, L.T. & Hines, D.M. (1994) Guidelines for blood utilisation review. Transfusion, 34, 438-448.
16. Toy, P.T.C.Y. (1994) Effectiveness of transfusion audits and practice guidelines. Archives of Pathology and Laboratory Medicine, 118, 435-437.
17. Welch, H.G., Meehan, K.R. & Goodnough, L.T. (1992) Prudent strategies for elective red blood cell transfusion. Annals of Internal Medicine, 116, 393-420.